Nicola Facciolongo Selected Research

Bronchial Thermoplasty

5/2022	Bronchial thermoplasty in severe asthma: a real-world study on efficacy and gene profiling.
12/2021	Bronchial Thermoplasty Global Registry (BTGR): 2-year results.
1/2021	A Real-World Evaluation of Clinical Outcomes of Biologicals and Bronchial Thermoplasty for Severe Refractory Asthma (BIOTERM).
1/2020	Biologics and Bronchial Thermoplasty for severe refractory asthma treatment: From eligibility criteria to real practice. A cross-sectional study.
9/2019	Competence in bronchial thermoplasty.
1/2019	European consensus meeting/statement on Bronchial Thermoplasty Who? Where? How?
1/2018	Heat-induced necrosis after bronchial thermoplasty: a new concern?
1/2017	Bronchial thermoplasty and the role of airway smooth muscle: are we on the right direction?
1/2017	Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty.
12/2016	The clinical profile of benralizumab in the management of severe eosinophilic asthma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicola Facciolongo Research Topics

Disease

28	Asthma (Bronchial Asthma) 05/2022 - 05/2011
8	COVID-19 10/2022 - 01/2020
6	Pneumonia (Pneumonitis) 10/2022 - 11/2010
4	Neoplasms (Cancer) 01/2021 - 03/2003
3	Fever (Fevers) 01/2021 - 01/2019
3	Cough 09/2019 - 01/2017
3	Inflammation (Inflammations) 01/2018 - 01/2016
3	Carcinoma (Carcinomatosis) 12/2005 - 03/2003
2	Disease Progression 11/2022 - 01/2021
2	Bronchiectasis 01/2022 - 01/2020
2	Respiratory Insufficiency (Respiratory Failure) 07/2021 - 01/2018
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2021 - 11/2010
1	Hypertension (High Blood Pressure) 01/2022
1	Infections 04/2021
1	Rhinosinusitis 01/2021
1	Systemic Vasculitis 01/2021
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2021
1	Vasculitis (Vasculitides) 01/2021
1	Nasal Polyps (Nasal Polyp) 01/2021
1	Malignant Mesothelioma 01/2021
1	Cytokine Release Syndrome 11/2020
1	Gastroesophageal Reflux (GERD) 01/2020
1	Mesothelioma 01/2019
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2019
1	Immunoglobulin G4-Related Disease 01/2019
1	Lymphadenopathy 01/2019
1	Pain (Aches) 01/2019
1	Glycogen Storage Disease Type II (Pompe's Disease) 01/2018
1	Necrosis 01/2018
1	Glycogen Storage Disease (Glycogenosis) 01/2018
1	Bronchial Spasm 01/2017
1	Pulmonary Atelectasis 01/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2012

Drug/Important Bio-Agent (IBA)

10	Omalizumab (Xolair)FDA Link 01/2022 - 05/2011
8	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2022 - 01/2015
8	mepolizumabIBA 01/2021 - 01/2016
7	Biological ProductsIBA 01/2022 - 01/2016
6	benralizumabIBA 01/2021 - 12/2016
5	tocilizumab (atlizumab)FDA Link 01/2022 - 01/2020
3	C-Reactive ProteinIBA 11/2022 - 01/2021
3	Monoclonal AntibodiesIBA 01/2021 - 01/2016
3	CytokinesIBA 10/2020 - 01/2016
3	Interleukin-5 (Interleukin 5)IBA 10/2020 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2019
2	AsbestosIBA 01/2021 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2021 - 12/2012
2	Interleukin-6 (Interleukin 6)IBA 11/2020 - 11/2020
2	SteroidsIBA 09/2019 - 05/2011
2	reslizumabIBA 01/2019 - 12/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022
1	Methylprednisolone FDA LinkGeneric 10/2022
1	GlucocorticoidsIBA 10/2022
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 05/2022
1	Messenger RNA (mRNA)IBA 05/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2021
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2020
1	Interleukin-13IBA 10/2020
1	Thymic Stromal LymphopoietinIBA 10/2020
1	ChemokinesIBA 10/2020
1	Interleukin-33IBA 10/2020
1	Interleukin-4 (Interleukin 4)IBA 10/2020
1	Chemokine CCL24IBA 10/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Interleukin-18 (Interleukin 18)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2019
1	Prednisone (Sone)FDA LinkGeneric 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019
1	dupilumabIBA 01/2019
1	alpha-Glucosidases (Acid Maltase)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	GlycogenIBA 01/2018
1	GlucosidasesIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	EnzymesIBA 01/2018
1	AcidsIBA 01/2018
1	Meperidine (Pethidine)FDA LinkGeneric 01/2017
1	Midazolam (Versed)FDA LinkGeneric 01/2017
1	Bronchodilator Agents (Bronchodilators)IBA 01/2015
1	FibrinIBA 01/2015
1	GoldIBA 12/2012
1	Immunoglobulin E (IgE)IBA 05/2011
1	Levofloxacin (Levaquin)FDA Link 11/2010
1	Etoposide (VP 16)FDA LinkGeneric 12/2005

Therapy/Procedure

12	Bronchial Thermoplasty 05/2022 - 07/2014
11	Therapeutics 10/2022 - 05/2011
4	Biological Therapy 01/2022 - 01/2017
3	Noninvasive Ventilation 07/2021 - 01/2015
2	Artificial Respiration (Mechanical Ventilation) 01/2020 - 01/2018
2	Precision Medicine 01/2018 - 01/2018
2	Drug Therapy (Chemotherapy) 12/2005 - 10/2003
1	Hospital to Home Transition 01/2022
1	Traction 01/2022
1	Continuous Positive Airway Pressure 07/2021
1	Personal Protective Equipment 04/2021
1	Nebulizers and Vaporizers (Inhaler) 01/2021
1	Catheters 09/2019
1	Tracheostomy 01/2018
1	Length of Stay 12/2012
1	Critical Care (Surgical Intensive Care) 11/2010